1265 related articles for article (PubMed ID: 8639401)
21. Whole abdominal radiotherapy versus combination chemotherapy with doxorubicin and cisplatin in advanced endometrial carcinoma (phase III): Gynecologic Oncology Group Study No. 122.
Randall ME; Spirtos NM; Dvoretsky P
J Natl Cancer Inst Monogr; 1995; (19):13-5. PubMed ID: 7577198
[TBL] [Abstract][Full Text] [Related]
22. Cyclophosphamide and cisplatin compared with paclitaxel and cisplatin in patients with stage III and stage IV ovarian cancer.
McGuire WP; Hoskins WJ; Brady MF; Kucera PR; Partridge EE; Look KY; Clarke-Pearson DL; Davidson M
N Engl J Med; 1996 Jan; 334(1):1-6. PubMed ID: 7494563
[TBL] [Abstract][Full Text] [Related]
23. Taxol in epithelial ovarian cancer.
Caldas C; McGuire WP
J Natl Cancer Inst Monogr; 1993; (15):155-9. PubMed ID: 7517152
[TBL] [Abstract][Full Text] [Related]
24. Long-term survival in advanced ovarian cancer after cytoreduction and chemotherapy treatment.
Del Campo JM; Felip E; Rubio D; Vidal R; Bermejo B; Colomer R; Zanon V
Gynecol Oncol; 1994 Apr; 53(1):27-32. PubMed ID: 8175018
[TBL] [Abstract][Full Text] [Related]
25. Salvage intraperitoneal therapy of ovarian cancer employing cisplatin and etoposide: a Gynecologic Oncology Group study.
Markman M; Blessing JA; Major F; Manetta A
Gynecol Oncol; 1993 Aug; 50(2):191-5. PubMed ID: 8375734
[TBL] [Abstract][Full Text] [Related]
26. Evidence supporting the superiority of intraperitoneal cisplatin compared to intraperitoneal carboplatin for salvage therapy of small-volume residual ovarian cancer.
Markman M; Reichman B; Hakes T; Rubin S; Lewis JL; Jones W; Barakat R; Curtin J; Almadrones L; Hoskins W
Gynecol Oncol; 1993 Jul; 50(1):100-4. PubMed ID: 8349150
[TBL] [Abstract][Full Text] [Related]
27. [Importance of platinum dose intensity in treatment of epithelial ovarian cancer. Austrian Study Group for Therapy of Ovarian Cancer].
Sevelda P; Kurz C; Obermair A; Vavra N; Breitenecker G; Czerwenka K; Dittrich C; Salzer H
Wien Klin Wochenschr; 1993; 105(24):732-6. PubMed ID: 8116312
[TBL] [Abstract][Full Text] [Related]
28. Controversial issues in the management of early epithelial ovarian cancer: conservative surgery and role of adjuvant therapy.
Colombo N; Chiari S; Maggioni A; Bocciolone L; Torri V; Mangioni C
Gynecol Oncol; 1994 Dec; 55(3 Pt 2):S47-51. PubMed ID: 7835811
[TBL] [Abstract][Full Text] [Related]
29. [Consensus and new development in epithelial ovarian cancer chemotherapy in 1995].
Hatae M; Onishi Y; Maeda Y; Nakamura T; Maeda T; Wada T
Gan To Kagaku Ryoho; 1995 Aug; 22(9):1182-9. PubMed ID: 7661570
[TBL] [Abstract][Full Text] [Related]
30. The platinum compounds and paclitaxel in the management of carcinomas of the endometrium and uterine cervix.
Thigpen T; Vance RB; Khansur T
Semin Oncol; 1995 Oct; 22(5 Suppl 12):67-75. PubMed ID: 7481864
[TBL] [Abstract][Full Text] [Related]
31. A phase II study of intraperitoneal carboplatin as adjuvant treatment in early-stage ovarian cancer patients.
Malmström H; Simonsen E; Westberg R
Gynecol Oncol; 1994 Jan; 52(1):20-5. PubMed ID: 8307496
[TBL] [Abstract][Full Text] [Related]
32. A phase II trial of piroxantrone in advanced ovarian carcinoma after failure of platinum-based chemotherapy: Southwest Oncology Group Study 8904.
Albain KS; Liu PY; Hantel A; Poplin EA; O'Toole RV; Wade JL; Maddox AM; Alberts DS
Gynecol Oncol; 1995 Jun; 57(3):407-11. PubMed ID: 7774846
[TBL] [Abstract][Full Text] [Related]
33. [The postoperative therapy of epithelial ovarian carcinoma. Has systemic cytostasis replaced percutaneous radiation?].
Souchon R; Cwiekala M
Strahlenther Onkol; 1995 Nov; 171(11):630-40. PubMed ID: 7502226
[TBL] [Abstract][Full Text] [Related]
34. Salvage chemotherapy for epithelial ovarian carcinoma.
Christian MC; Trimble EL
Gynecol Oncol; 1994 Dec; 55(3 Pt 2):S143-50. PubMed ID: 7835799
[TBL] [Abstract][Full Text] [Related]
35. Cytoreductive surgery in ovarian carcinoma patients with a documented previously complete surgical response.
Vaccarello L; Rubin SC; Vlamis V; Wong G; Jones WB; Lewis JL; Hoskins WJ
Gynecol Oncol; 1995 Apr; 57(1):61-5. PubMed ID: 7705701
[TBL] [Abstract][Full Text] [Related]
36. Management of early ovarian cancer: germ cell and sex cord-stromal tumors.
Gershenson DM
Gynecol Oncol; 1994 Dec; 55(3 Pt 2):S62-72. PubMed ID: 7530680
[TBL] [Abstract][Full Text] [Related]
37. Phase II trial of etoposide, carboplatin, and ifosfamide as salvage therapy in advanced ovarian carcinoma.
Beddoe AM; Dottino PR; Cohen CJ
Mt Sinai J Med; 1993 Sep; 60(4):311-6. PubMed ID: 8232377
[TBL] [Abstract][Full Text] [Related]
38. Is there a role for consolidation or salvage radiotherapy after chemotherapy in advanced epithelial ovarian cancer?
Thomas GM
Gynecol Oncol; 1993 Oct; 51(1):97-103. PubMed ID: 8244182
[TBL] [Abstract][Full Text] [Related]
39. Primary treatment of stage III ovarian carcinoma with sequential chemotherapy and whole abdominal radiation therapy.
Reid GC; Roberts JA; Hopkins MP; Schoeppel SL; Perez-Tamayo C; Drescher C; Chamberlain D; Morley GW
Gynecol Oncol; 1993 Jun; 49(3):333-8. PubMed ID: 8314535
[TBL] [Abstract][Full Text] [Related]
40. Epithelial ovarian cancer: impact of surgery and chemotherapy on survival during 1977-1990.
Venesmaa P
Obstet Gynecol; 1994 Jul; 84(1):8-11. PubMed ID: 8008329
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
